Retifanlimab, sold under the brand name Zynyz, is an anti-cancer medication used for the treatment of Merkel cell carcinoma. Retifanlimab is a programmed...
11 KB (764 words) - 22:04, 29 May 2025
mismatch repair deficient (dMMR) recurrent or advanced solid tumors. Retifanlimab (Zynyz) was developed by Incyte and first granted accelerated approval...
35 KB (3,427 words) - 21:49, 29 May 2025
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
49 KB (4,951 words) - 21:41, 29 May 2025
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
9 KB (640 words) - 21:57, 7 March 2025
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
38 KB (3,237 words) - 20:38, 29 May 2025
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
83 KB (7,695 words) - 21:50, 29 May 2025
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
31 KB (2,975 words) - 20:40, 29 May 2025
Pidilizumab Plozalizumab PRO 140† Quilizumab Ravulizumab Reslizumab Retifanlimab Rontalizumab Rovelizumab Ruplizumab Samalizumab Satralizumab Siplizumab...
38 KB (4,316 words) - 01:22, 4 February 2025
the original on 12 November 2021. Retrieved 12 November 2021. "ZYNYZ™ (retifanlimab-dlwr) injection, for intravenous use" (PDF). Archived (PDF) from the...
142 KB (4,345 words) - 21:22, 29 May 2025
L01FF07 Dostarlimab L01FF08 Prolgolimab L01FF09 Tislelizumab L01FF10 Retifanlimab L01FF11 Sugemalimab L01FF12 Serplulimab L01FF13 Toripalimab L01FG01 Bevacizumab...
13 KB (932 words) - 04:36, 23 December 2024
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
45 KB (4,269 words) - 20:02, 29 May 2025
Pembrolizumab Penpulimab Polatuzumab vedotin Prolgolimab Ramucirumab Retifanlimab Sabatolimab Sacituzumab govitecan Serplulimab Sugemalimab Tafasitamab...
12 KB (829 words) - 20:43, 29 May 2025
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
12 KB (1,015 words) - 21:50, 29 May 2025
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
7 KB (363 words) - 03:23, 25 January 2025
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
13 KB (1,068 words) - 20:18, 29 May 2025
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
16 KB (1,479 words) - 20:04, 29 May 2025
Pembrolizumab Penpulimab Polatuzumab vedotin Prolgolimab Ramucirumab Retifanlimab Sabatolimab Sacituzumab govitecan Serplulimab Sugemalimab Tafasitamab...
12 KB (731 words) - 21:34, 29 May 2025
Pidilizumab Plozalizumab PRO 140† Quilizumab Ravulizumab Reslizumab Retifanlimab Rontalizumab Rovelizumab Ruplizumab Samalizumab Satralizumab Siplizumab...
2 KB (87 words) - 01:28, 30 May 2023
protein 1 Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Toripalimab PD-L1 inhibitorsTooltip Programmed death-ligand 1 AUNP12...
2 KB (160 words) - 17:49, 8 March 2025